| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Verdoorn Todd A. is a Chief Scientific Officer at DiaMedica Therapeutics Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $12K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2018 | DMAC Diamedica Therapeutics Inc. | Chief Scientific Officer | Buy | 1,000 | $4.00 | $4,000.00 | +100.0% |